Vnitr Lek 2023, 69(2):E26-E30 | DOI: 10.36290/vnl.2023.026

Diabetes mellitus urological complication

Miroslava Ryšánková
Urologie Náchod, s. r. o.

Diabetes mellitus is a disease characterized by chronic hyperglycaemia due to an absolute or relative lack of insulin. The disease mainly affects the nervous system, and the urological complications themselves develop on the basis of these disorders. Urological patients with diabetes present in ambulance with manifestations of common urological diseases, but also suffer from complications of the urinary system or genital organs that are specific for diabetic patient. Usually, these complications go unrecognized for a long time or manifest only non-specifically. But they are often life-threatening for patients. Treatment does not consist only in urological stabilization, but stabilization of the diabetes itself is also necessary. It can be said that diabetes increases the risk of urological problems, and on the contrary, urological problems (especially inflammation) can lead to decompensation of the patient's diabetes.

Keywords: diabetes mellitus, diabetic nephropathy, diabetic cystopathy, Fournier's gangrene, emphysematous pyelonephritis, renal papillary necrosis.

Accepted: March 29, 2023; Published: March 30, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ryšánková M. Diabetes mellitus urological complication. Vnitr Lek. 2023;69(2):E26-30. doi: 10.36290/vnl.2023.026.
Download citation

References

  1. Češka R, et al. Interna. 3. vydání, Praha: Triton, 2020; 970 s.
  2. Pelikánová T, Bartoš V. Praktická diabetologie. 6 ed. Praha: Maxdorf, 2018; 815 s.
  3. Wein K, Novick PP. Campbell‑Walsh Urology 2007:271-273.
  4. Brix AE. Renal papillary necrosis. Toxicol Pathol. 2002;30(6):672-4. Go to original source... Go to PubMed...
  5. Panach‑Navarrete J, Medina‑González M, Lorena Alarcón‑Molero L, et al. Renal papillary necrosis, an endoscopic vision. Scand J Urol. 2019;53(5):361-363. Go to original source... Go to PubMed...
  6. Lacigová S, Rušavý Z, Jirkovská A, et al. Doporučený postup diagnostiky a léčby diabetické neuropatie (2016), Doporučení české diabetické společnosti ČLS JEP, datum revize 23. 2. 2016, dmev; 2016,19(2):57-63.
  7. Yuan Z, Tang Z, He Ch, et al. Diabetic cystopathy: A review. J Diabetes. 2015;7(4):442-7. Go to original source... Go to PubMed...
  8. Ryšánková M. Dysfunkce dolních cest močových u diabetického pacienta. Urol. praxi. 2022;23(1):193-7. Go to original source...
  9. Wittig L, Carlson KV, Andrews JM, et al. Diabetic Bladder Dysfunction: A Review. Urology. 2019;123:1-6. Go to original source... Go to PubMed...
  10. MINIRIN, Souhrn údajů o přípravku, sp. zn. Sukl s 185737/2018.
  11. Lieske JC. Diabetes mellitus and the risk of urinary tract stones: a population‑based case‑control study. Am J Kidney, DiS. 2006;48:897-904. Go to original source... Go to PubMed...
  12. Broďák M, Romžová M, Košina J. Urologické výkony u diabetika. Vnitr Lek. 2008;54(5):457-463. Go to PubMed...
  13. Venmans LM, Sloof M, Hak E, et al. Prediction of complicated urinary tract infections with type 2 diabetes: a questionnaire study in primary care. Eur J Epidemiol. 2007;22(1):49-54. Go to original source... Go to PubMed...
  14. Hrnčiříková A, Vachek J. Nebezpečné léky u nemocných s renálním poškozením - kdy a jak redukovat dávky. Med. Praxi. 2016;13(4):176-179. Go to original source...
  15. Kladenský J. Infekce močových cest a diabetes mellitus. Urol. praxi. 2013;14(2):56-58.
  16. Wang Z, Olumi AF. Diabetes, growth hormone‑insulin‑like growth factor pathways and association to benign prostatic hyperplasia. Diferentiation. 2011;82(4-5):261-71. Go to original source... Go to PubMed...
  17. Park SM, Lim MK, Shin SA, Yun YH. Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol. 2006;24:5017-5024. Go to original source... Go to PubMed...
  18. Evans JM, Donnelly LA, Emslie‑Smith AM, et al. Metformin and reduced risk of cancer in diabetic patients. BMJ. 2005;330:1304-1305. Go to original source... Go to PubMed...
  19. Stone HH, Martin JD Jr. Synergistic necrotizing cellulitis. Ann Surg. 1972;175(5):702-711. Go to original source... Go to PubMed...
  20. Fournier JA. Gangrène‑foudroyante de la verge. Semin Med. 1883;3:345.
  21. Tang LM, Su YJ, Lai YC. The evaluation of microbiology and prognosis of fournier's gangrene in past five years. Springerplus. 2015;4:14. Go to original source... Go to PubMed...
  22. Broďák M, Romžová M, Košina J. Urologické výkony u diabetika. Vnitr Lek. 2008;54(5):457-463. Go to PubMed...
  23. Isidro ML. Sexual dysfunction in men with type 2 diabetes. Postgrad Med J. 2012; 88(1037):152-159. Go to original source... Go to PubMed...
  24. Pederson DF, Latini DM, Lubeck DP, et al. Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than general population of impotent patients? Diabetes Care. 2003;26(4):1093-1099. Go to original source... Go to PubMed...
  25. Haffner SM, Shaten J, Stern MP, et al. Low levels of sex hormo‑ne‑binding globulin and testosterone predict the development of non‑insulin‑dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1996;143:889-897. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.